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MObjective: Early readmission in patients hospitalized for medical congestive heart failure is common, expen-
sive, and associated with a worse late survival. Our objective was to compare late survival in patients’ readmis-
sion for congestive heart failure with readmission for other causes in patients undergoing cardiac surgery.
Methods: Of 3654 consecutive patients undergoing cardiac surgery at a single institution between April 2004
and June 2010, 3492 (96%) were discharged from the hospital before 30 days and analyzed. Survival curves by
readmission reason were compared using the log-rank test. Multivariable analyses adjusted for patient demo-
graphics, known preoperative cardiac risk factors, and surgical characteristics.
Results: The readmission rate at 30 days was 13% (465/3492): 23% for arrhythmias/heart block, 12% for con-
gestive heart failure, 40% for surgery related causes, 14% for infection, and 11% for noncardiac causes. Inde-
pendent risk factors for readmission include age, gender, congestive heart failure, and cardiopulmonary bypass
time. Eight percent (268/3492) of discharged patients died within the 6-year study: 14% in the readmission
group versus 7% in the nonreadmission group (P<.01). Patients who had been readmitted for congestive heart
failure had worse late survivals compared with all patients who had been readmitted for causes related to their
surgery.
Conclusions: Readmission within 30 days after cardiac surgery for congestive heart failure predicts late mor-
tality. Targeted postoperative management may be warranted in patients with surgical congestive heart failure.
(J Thorac Cardiovasc Surg 2012;144:671-6)Early readmission is common in patients hospitalized for
medical congestive heart failure (CHF). Estimated 30-day
readmission rates approach 25%1,2 among patients with
previous heart failure hospitalization. In the elderly
population, readmission rates may be as high as 45%.3,4
Frequent readmissions are associated with high personal
and shared medical costs, and burden the already stressed
health care system. In addition to its monetary consequence,
readmission has long served as a predictor of worse patient
outcomes. All-cause readmission after heart failure hospitali-
zation has proven to be a predictor of both 1-year and total
mortality in elderly outpatient populations.5,6
Although early readmission has been widely studied in
the population with medical heart failure, limited data avail-
ability precluded an accurate description of the relationship
between early readmission and late outcomes after cardiac
surgery. The Society of Thoracic Surgeons National Data-
base reports 30-day readmission rates within this patient
population to range from 9.0% to 14.5%, varying bye Bluhm Cardiovascular Institute, Northwestern University, Chicago, Ill.
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The Journal of Thoracic and Casurgery type.7 As in medical heart failure readmission, read-
mission in the population who underwent cardiac surgery is
expensive and believed to be associated with poorer out-
comes. However, this patient population requires separate
study because readmission causes and subsequent outcomes
differ from those of patients with nonsurgical heart failure.
Our objective was to define the impact of 30-day readmis-
sion on late survival after cardiac surgery, with specific
focus on those patients’ readmission for CHF.
PATIENTS AND METHODS
A total of 3654 patients underwent cardiac surgery at Northwestern
Memorial Hospital between April 2004 and June 2010. This project was
approved by the institutional review board at Northwestern University
(institutional review board project STU000012288). Any subject refusing
participation in the project was not included in this analysis. Included sur-
geries were aortic and mitral valve repairs and replacements, coronary
artery bypass grafting (CABG), and combined procedures. All ventricular
assist device and transplant recipients were excluded from study. The re-
maining 3492 patients (96%) discharged from the hospital before 30
days after surgery constitute our study population. Their institutional data-
base records were retrospectively collected and analyzed. All readmissions
to Northwestern Hospital were included from institutional records. In addi-
tion, readmissions from outside hospitals were determined by a mailed sur-
vey that inquired of any hospital admissions or procedures since discharge
and included an information release form to allow our data collection from
other institutions. Readmission occurrence and reason were determined
and adjudicated by Northwestern University’s Bluhm Cardiovascular Insti-
tute Clinical Trials Unit staff based on institutional progress notes and
discharge summaries in accordance with the Society of Thoracic Surgeons
database.7 Readmission reasons were grouped into 5 categories:rdiovascular Surgery c Volume 144, Number 3 671
TABLE 1. Univariate risk factors for 30-day readmission
Variable OR 95% CI P value
Age by decade 1.13 1.05-1.22 .002
Gender, female 1.32 1.07-1.62 .009
Diabetes 1.31 1.03-1.67 .027
Renal failure requiring dialysis 1.79 1.00-3.21 .049
Hypertension 1.28 1.03-1.59 .026
Prior cardiac intervention 1.28 1.04-1.57 .019
Prior valve surgery 1.46 1.02-2.08 .041
CHF 1.52 1.22-1.90 <.001
NYHA class III/IV 1.34 1.09-1.64 .005
History of atrial fibrillation 1.41 1.12-1.77 .003
Preoperative anticoagulant use 1.33 1.01-1.75 .041
Preoperative aspirin use 1.30 1.05-1.62 .018
Preoperative beta-blocker use 1.33 1.08-1.64 .007
Preoperative antiarrhythmic use 1.48 1.02-2.13 .037
LVEF by 10% 0.92 0.85-0.99 .026
Coronary artery disease 1.40 1.03-1.91 .030
Tricuspid insufficiency  2þ 1.52 1.15-2.02 .004
CABG procedure 1.09 0.90-1.33 .385
Aortic valve surgery 1.13 0.92-1.38 .236
Mitral valve surgery 1.01 0.82-1.25 .921
Tricuspid valve surgery 1.75 1.26-2.44 <.001
Other cardiac surgery 1.33 1.09-1.61 .005
Atrial fibrillation ablation surgery 1.40 1.09-1.79 .008
Cardiopulmonary bypass time (h) 1.29 1.16-1.44 <.001
Crossclamp time (h) 1.30 1.13-1.50 <.001
Intraoperative blood products used 1.46 1.19-1.79 <.001
Postoperative blood products used 1.32 1.08-1.61 .006
Readmission to the ICU 1.92 1.29-2.85 .001
Length of stay (d) 1.04 1.02-1.06 <.001
OR, Odds ratio; CI, confidence interval; CHF, congestive heart failure; NYHA, New
York Heart Association; LVEF, left ventricular ejection fraction; CABG, coronary ar-
tery bypass grafting; ICU, intensive care unit.
Abbreviations and Acronyms
BMI ¼ body mass index
CABG ¼ coronary artery bypass grafting
CHF ¼ congestive heart failure
CI ¼ confidence interval
OR ¼ odds ratio
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M(1) arrhythmia, (2) CHF, (3) infection (deep sternum, conduit harvest site,
or pneumonia), (4) surgery-related reason (acute vascular complication, an-
ticoagulation complication, coronary artery dysfunction, myocardial in-
farction, pericardial effusion or tamponade, permanent cerebrovascular
accident, renal failure or transient ischemic attack, or other surgery-
related readmission, including surgical complications such as graft failure),
and (5) nonrelated reason (including gastrointestinal complications and
bleeds). Mortality was ascertained by Social Security Death Index and tele-
phone follow-up.
Statistical Analyses
The association between every baseline variable (patient demographics,
preoperative variables, and surgical characteristics) and 30-day readmis-
sion status was measured using a series of univariate logistic regression
models. Variables significant at a 2-sided 5% alpha level are shown in
Table 1. Variables in Table 1 were used as the initial pool of factors to create
a multivariate logistic regression model. A stepwise variable selection pro-
cedure with 10% entry/exit significance levels was performed. The result-
ing multivariate logistic regression model was subsequently adjusted for
surgical procedure type (isolated CABG, isolated valve, and CABG þ
valve). All significant variables in the final model are presented in
Table 2. A similar approach was used to construct a multivariate model
for 30-day CHF readmission. As such, variables significantly associated
with 30-day CHF readmission in univariate and multivariate fashion are
shown in Tables 3 and 4, respectively. All-cause long-term mortality was
summarized using Kaplan–Meier survival curves. Overall survivorship
comparisons between the readmission and nonreadmission groups were
based on the log-rank test. A Cox regression model that adjusts for surgical
procedure and all the univariate 30-day readmission predictors listed in
SAS 9.2 software (SAS Inc, Cary, NC) was used to perform all statistical
analyses. Statistical significance was established at the 2-sided 5% alpha
level, and no multiplicity adjustments were made.
RESULTS
Some 66% of our patient population was male (2321/
3492) with a mean body mass index (BMI) of 28.0
( 5.8). Mean age was 63.2  13.7 years, and 81% of
surgeries were elective.
Risk Factors for 30-Day All-Cause Readmission
After Cardiac Surgery
Of the 3492 patients discharged within 30 days of cardiac
surgery, 465 (13%) required hospital readmission within 30
days of surgery. Of these patients, 23% were readmitted for
arrhythmia or heart block, 12% were readmitted for CHF,
14% were readmitted for infection, 40% were readmitted
for surgery-related reasons, and 11% were readmitted for
nonrelated reasons (Table 5).
Significant univariate 30-day readmission risk factors are
shown in Table 1. They include age, gender, history of CHF,672 The Journal of Thoracic and Cardiovascular Surgand New York Heart Association class III or IV. Initial
length of hospital stay was also a significant predictor for
early readmission: mean 7.67  4.17 days for readmission
versus 7  3.88 days for nonreadmission (odds ratio [OR],
1.04; 95% confidence interval [CI], 1.02-1.06; P<.001).
Independent multivariate predictors for 30-day readmission
presented in Table 2 are age (OR, 1.13 per decade), female
gender (OR, 1.29), history of CHF (OR, 1.29), cardiopul-
monary bypass time (OR, 1.30 per hour), and readmission
to the intensive care unit (OR, 1.53).Risk Factors for 30-Day Congestive Heart Failure
Readmission After Cardiac Surgery
Significant univariate 30-day CHF readmission risk fac-
tors are shown in Table 3 and include age, gender, history
of CHF, history of atrial fibrillation, and initial length of
hospital stay: median 8 (interquartile range, 6-12) days in
CHF readmission versus 6 (interquartile range, 5-8) days
in CHF nonreadmission (OR, 1.11; 95% CI, 1.06-1.16;
P< .001). Independent multivariate predictors for 30-day
readmission presented in Table 2 are history of CHFery c September 2012
TABLE 2. Multivariate risk factors for 30-day readmission
Characteristics OR 95% CI P value
Age by decade 1.13 1.04-1.23 .006
Gender, female 1.30 1.04-1.63 .019
CHF 1.31 1.03-1.66 .028
Cardiopulmonary bypass time 1.31 1.17-1.47 <.001
Readmission to the ICU 1.52 0.98-2.36 .059
Variables entered into the model include age; gender; diabetes; dialysis; hyperten-
sion; previous cardiac intervention or valve surgery; CHF; New York Heart Associ-
ation class III/IV; history of atrial fibrillation; anticoagulant, aspirin, beta-blocker,
and antiarrhythmic use; ejection fraction; coronary artery disease; tricuspid regurgi-
tation 2þ; tricuspid valve surgery; atrial fibrillation ablation surgery; cardiopulmonary
bypass time; crossclamp time; intraoperative and postoperative blood products; read-
mission to the intensive care unit; and length of stay. OR, Odds ratio; CI, confidence
interval; CHF, congestive heart failure; ICU, intensive care unit.
TABLE 4. Multivariable analyses: Risk factors for 30-day readmission
for congestive heart failure
Characteristics OR 95% CI P value
CHF 2.89 1.42-5.86 .003
History of atrial fibrillation 4.94 2.33-10.46 <.001
Preoperative aspirin use 2.31 1.14-4.66 .020
LVEF by 10% 0.78 0.62-0.98 .034
Postoperative blood products used 2.81 1.42-5.57 .003
Variables entered into the model include age, dyslipidemia, chronic lung disease, pe-
ripheral vascular disease, previous cardiac intervention, previous CABG, previous
percutaneous coronary intervention, myocardial infarction, CHF, New York Heart
Association class III/IV, history of atrial fibrillation, warfarin (Coumadin) and aspirin
use, ejection fraction, coronary artery disease, left main disease, tricuspid regurgita-
tion 2þ, repeat sternotomy, intraoperative and postoperative blood products, total
hours in the intensive care unit, and length of stay. OR, Odds ratio; CI, confidence
interval; CHF, congestive heart failure; LVEF, left ventricular ejection fraction.
Lee et al Perioperative Management(OR, 3.36), history of atrial fibrillation (OR, 3.16), preoper-
ative aspirin use (OR, 2.24), and postoperative blood prod-
ucts (OR, 2.80).P
MOverall 30-Day Readmission Predicts Late Mortality
Eight percent (268/3492) of patients discharged within
30 days after cardiac surgery died during the 6-year study
period: 14% of the readmission group and 7% of the non-
readmission group (P<.001) (Figure 1).TABLE 3. Risk factors for readmission in those readmitted for
congestive heart failure, univariate analysis
Characteristics OR 95% CI P value
Age by decade 1.33 1.04-1.69 .022
Dyslipidemia 2.08 1.09-3.95 .026
Chronic lung disease 2.10 1.06-4.15 .034
Peripheral vascular disease 2.60 1.08-6.26 .033
Prior cardiac intervention 3.22 1.80-5.77 <.001
Prior CABG 3.69 1.79-7.58 <.001
Prior PCI 2.15 1.06-4.35 .033
Prior MI 2.88 1.47-5.65 .002
CHF 3.51 1.92-6.44 <.001
NYHA class III/IV 2.69 1.50-4.82 <.001
History of atrial fibrillation 3.29 1.74-6.24 <.001
Preoperative warfarin
(Coumadin; Bristol-Myers
Squibb, New York, NY) use
3.09 1.31-7.27 .010
Preoperative aspirin use 2.33 1.28-4.25 .006
LVEF by 10% 0.69 0.56-0.84 <.001
Coronary artery disease 2.27 1.02-5.07 .045
Left main disease 2.94 1.22-7.10 .017
Tricuspid insufficiency  2þ 2.66 1.34-5.26 .005
Repeat sternotomy 2.95 1.56-5.58 <.001
Intraoperative blood products used 3.17 1.53-6.53 .002
Postoperative blood products used 3.23 1.69-6.17 <.001
Total hours in the ICU 1.01 1.00-1.01 .003
Length of stay (d) 1.09 1.03-1.16 .002
All models are adjusted for type of surgery: isolated CABG, isolated valve, and
CABGþvalve. OR, Odds ratio; CI, confidence interval; CABG, coronary artery by-
pass grafting; PCI, percutaneous coronary intervention; MI, myocardial infarction;
CHF, congestive heart failure; NYHA, New York Heart Association; LVEF, left ven-
tricular ejection fraction; ICU, intensive care unit.
The Journal of Thoracic and CaAfter adjusting for surgical procedure type (isolated
CABG, isolated valve, and CABGþ valve) and all other
univariate predictors in Table 1, 30-day readmission
remained a statistically significant predictor of late mortal-
ity (hazard ratio, 1.45; 95% CI, 1.04-2.02; P ¼ .028).
Late Mortality Rates by Readmission Reason
Patients readmitted for CHF and noncardiac-related
reasons had the highest long-term mortality rates (Table 6).
Kaplan–Meier survival curves were created for the nonread-
missiongroup and 5 readmission groups (Figure 2), andwere
compared using the log-rank test. Readmission for CHFwas
found to be associated with significantly worse late survival
than nonreadmission and all other readmission causes re-
lated to surgery (log-rank, 7.60; P¼ .006). Patients readmit-
ted for noncardiac-related causes had similar late survival as
those readmitted for CHF (log-rank, 0.71; P ¼ .397).TABLE 5. Thirty-day readmission patient classification (N ¼ 465)
Readmission reason N %
Arrhythmia/heart block 105 22.6
CHF 56 12.0
Infection 67 14.4
Deep sternum 13 2.8
Conduit harvest site 15 3.2
Pneumonia 39 8.4
Surgery-related reason 184 39.6
Acute vascular complication 3 0.7
Anticoagulation complication 8 1.7
Coronary artery dysfunction 1 0.2
Myocardial infarction 8 1.7
Pericardial effusion or tamponade 17 3.7
Permanent CVA 8 1.7
Renal failure 3 0.7
TIA 7 1.5
Other surgery-related readmission 129 27.7
Nonrelated reason 53 11.4
Total readmissions 465
CHF, Congestive heart failure; CVA, cerebrovascular accident; TIA, transient ische-
mic attack.
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FIGURE 1. Kaplan–Meier survival curves by 30-day readmission status (log-rank, 28.9; P<.001).
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MReadmission for surgery-related reasons was associated
with a significantly lower rate of survival compared with
nonreadmission (log-rank, 11.83; P< .001). Readmission
for infection was not associated with worse late survivals
compared with nonreadmission (log-rank, 2.25; P ¼ .134).
Readmission for arrhythmia was associated with signifi-
cantly lower latemortalitywhen comparedwith readmission
for all other causes (log-rank, 11.70; P<.001).DISCUSSION
Readmission after cardiac surgery is common and associ-
ated with worse outcomes.1-4 Although the correlation
between readmission and late mortality has been
established in a patient population with medical CHF,
limited data exist on the effect of early readmission on
outcomes after cardiac surgery.
This study found older age, female gender, CHF, and in-
creased cardiopulmonary bypass time to be significantly as-
sociated with 30-day readmission. Kumbhani and
colleagues8 reported intraoperative myocardial acidosis to
also predict readmission after cardiac surgery. This variable
was not analyzed in this study, but this and other surgical
complications are also potential risk factors forTABLE 6. Readmission reasons by all-cause long-term mortality
Readmission reason
No. deceased/no.
readmitted % Deceased
Arrhythmia 4/105 3.8
CHF 16/56 28.6
Infection 8/67 11.9
Nonrelated reason 13/53 24.5
Surgery-related reason 25/184 13.6
Total 66/465 14.2
CHF, Congestive heart failure.
674 The Journal of Thoracic and Cardiovascular Surgreadmission. Rockx and colleagues9 found that a BMI
greater than 30 is predictive of early readmission. However,
BMI was not found to be associated with higher readmis-
sion rates in this study. Because elevated BMI is linked to
an increased risk of sternal wound and leg infections, of
which this study had few, high BMI-related complications
did not lead to a significant increase in readmissions. This
study also analyzed BMI on a continuous numeric spectrum
instead of grouping patients by designated BMI range as in
the study by Rockx and colleagues.
Lahey and colleagues10 found that patients postopera-
tively discharged after 7 or more days were twice as likely
to be readmitted as those discharged sooner. We also found
initial length of hospital stay was significantly associated
with early readmission in univariate models, but not in mul-
tivariate analysis. However, we did not isolate and further
analyze the subgroup of patients with extremely long
lengths of stay.
Our data suggest that not all readmissions, but specifi-
cally CHF and nonsurgery-related readmissions, are associ-
ated with reduced survival. Readmission for CHF was
associated with higher mortality than all other surgery-
specific readmission and nonreadmission groups. This
study identifies CHF as a risk factor for both all-cause
and CHF-related early readmission. In addition, it is associ-
ated with increased all-cause long-term mortality. Thus, pa-
tients with CHF are a high-risk group for elevated hospital
costs and worse outcomes. It is not surprising that the pre-
operative presence of CHF and a lower ejection fraction
are associated with readmission in this group. However,
these data further support the role of atrial fibrillation as
a marker or cause of a sicker population within the CHF
group. After further validation of these findings, to reduce
both readmission and subsequent mortality, targetedery c September 2012
FIGURE 2. Kaplan–Meier overall survival curves by 30-day readmission status and reason. Kaplan–Meier survival curves for all readmitted types and
nonreadmitted patients. CHF, Congestive heart failure.
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Mstrategies could be developed to identify and treat high-risk
patients with CHF undergoing cardiac surgery. Patients re-
admitted for noncardiac-related reasons, such as gastroin-
testinal complications, had late survival similar to those in
the CHF readmission group. These patients may also benefit
from targeted preventative therapies.
Patients readmitted for infection did not have different
survival from those not readmitted. Filsoufi and col-
leagues11 alternatively found deep sternal wound infections
after cardiac surgery to be associated with increased mortal-
ity. The small number of sternal wound infections in this
study limited the analysis in our population. Certainly, if
there were more sternal infections, there may be a different
result. However, prevention remains the best method to ad-
dress this problem.
Of note, readmission for arrhythmias was associated with
better survival than nonreadmission. This is likely due to the
group’s overall healthier patient population. The presence
of comorbidities also tended to be less in this group com-
pared with other readmission and nonreadmission groups,
including preoperative hypertension, diabetes, chronic ob-
structive pulmonary disease, and prior myocardial infarc-
tion or stroke.
This study has several limitations. It was performed at
a single institution, which may reduce its widespread appli-
cability because of differences in patient populations and
care practices among treatment centers. Although extensive
effort was made to identify all the readmissions in the
study, some outside readmissions may not be reported.
However, patient characteristics, overall readmission rate,
and proportion of patients within readmission reason
groups were similar to those reported in the Society of Tho-
racic Surgeons national database. The Society of Thoracic
Surgeons national average readmission rate for all valve
heart surgery, CABG, and combined procedures isThe Journal of Thoracic and Ca11.8%: 13.8% for arrhythmias, 15.8% for CHF, 20% for
all infections, 15.1% for surgery-related reasons (including
2.1% myocardial infarction and 2.2% stroke), and 35.3%
for nonrelated reasons,7 which is comparable to our
experience.
Further, study duration is limited to 6 years and a rela-
tively small population. To perform statistical analyses, re-
admission types were grouped into 5 categories. The
readmission groups for infection, surgery-related reasons,
and nonrelated reasons were particularly heterogeneous,
with the possibility that certain subgroups directionally
shifted associated trends. If a larger patient population
was available for study, additional readmission groups could
be analyzed to more specifically pinpoint high-risk patients.
Finally, unknown confounders are always a concern in
retrospective studies. Determination of unknown causes
for readmission and worse late survival are of importance
because readmission is not itself a cause but a predictor of
late mortality.CONCLUSIONS
Despite the study’s limitations, to the best of our knowl-
edge, this is the first systematic study of the relationship be-
tween early readmission and late mortality in a patient
population undergoing cardiac surgery. Our data suggest
that not all readmission reasons incur increased mortality,
but similar to the population with medical CHF, patients
with surgical CHF who are readmitted postoperatively
fare worse. Early identification of patients at risk for read-
mission and targeted postoperative management strategies
may lead to improved survival.References
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